Thu, Jul 10, 2014, 7:53 AM EDT - U.S. Markets open in 1 hr 37 mins


% | $
Quotes you view appear here for quick access.

Focus Media Holding Ltd. Message Board

fretfulporpentine 15 posts  |  Last Activity: Jul 3, 2014 10:21 AM Member since: Oct 2, 2011
  • Reply to

    former CHK calls

    by gladysz Jul 2, 2014 7:38 PM fretfulporpentine Jul 3, 2014 10:21 AM Flag

    For a covered call the deliverable used to be 100 CHK. Now the options are called CHK1 and the deliverable is 100 CHK, 7 SSE.

    Sentiment: Hold

  • Reply to


    by rajiv20_2003 Jul 1, 2014 11:57 AM fretfulporpentine Jul 1, 2014 1:22 PM Flag

    Call your broker and ask that your cancelled shares receive the same amount in cash as those tendered. You will simply have to wait longer for the money than those who tendered. Read the 14D-9 and 8-K filed with the SEC.

    As described in Chelsea' Solicitation/Recommendation Statement on Schedule 14D-9 (the "Statement") filed with the Securities and Exchange Commission (the "SEC") and mailed to Chelsea's stockholders on May 23, 2014, Chelsea's Board of Directors has unanimously recommended that Chelsea's stockholders accept the Offer and tender their shares pursuant to the Offer. The initial expiration date of the Offer is at 12:00 midnight, New York City time, on June 20, 2014 (one minute after 11:59 p.m., New York City time, on June 20, 2014), subject to extension in certain circumstances as permitted under the Merger Agreement and applicable law.
    Subject to Acquisition Sub's irrevocable acceptance for payment in the Offer of at least a majority of Chelsea's common stock outstanding on a fully diluted basis and to the satisfaction or waiver of certain other customary conditions, Acquisition Sub will merge with and into the Company (the "Merger") and, subject to certain exceptions, each Chelsea share not tendered in the Offer will be cancelled and converted into the right to receive in the Merger the same consideration per share paid in the Offer. The Merger will be effected as soon as practicable after the closing of the Offer.

    From the 8-K
    Pursuant to the Merger Agreement, at the Effective Time each outstanding Share (other than Shares owned by the Company, Parent or Acquisition Sub, by any direct or indirect wholly owned subsidiary of the Company, Parent or Acquisition Sub or by stockholders of the Company who have validly perfected their statutory rights of appraisal under the DGCL with respect to such Shares) was converted into the right to receive the Merger Consideration

    Sentiment: Hold

  • Reply to

    Charles Schwab - CHTP Calculation error

    by chrispaulisa Jun 27, 2014 11:53 AM fretfulporpentine Jun 29, 2014 1:58 AM Flag

    Yes, Schwab made the error of giving me a cost basis of $0 and the proceeds of the tender as pure profit in the Realized Gain/Loss page. As they were held in an IRA I'm not too concerned but will call them up to get it fixed.

    Incidentally this message board will go away once the stock is delisted so it will be difficult to keep up with the further adventures of the CVRs unless we set up a yahoo group or something.

    Sentiment: Hold

  • by fretfulporpentine Jun 26, 2014 10:56 AM Flag

    Well finally! These dam' Chinese privatization deals simply cannot get their acts together in a reasonable amount of time. Witness the "logistics" feckup at YONG and the almost complete freezeup at GAGA.

  • by fretfulporpentine Jun 22, 2014 12:28 AM Flag

    Now that Shire PLC (SHPG) is in play is SNN next in line? I saw at least three articles last week.

    (1) Needham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal 6/16/2014
    ... think Smith & Nephew (NYSE: SNN) has become increasingly attractive to suitors and that it is all but inevitable that Stryker Corp. (NYSE: SYK) attempts to acquire SNN. However, they note SNN may not be a willing seller, and we think SYK could end up in a similar situation as Pfizer (PFE) after it was spurned by AstraZeneca (AZN).

    (2) Smith & Nephew (SNN) Still Seen as Takeover Target Amid Medtronic/Covidien Deal - Summer Street
    8:49 AM ET, 06/16/2014 - Street Insider
    Summer Street analyst Mark Landy reiterated a Buy rating and $112 price target on Smith & Nephew (NYSE: SNN) saying they continue to view the company as a prime acquisition target despite this weekend's Medtronic (NYSE: MDT)/Covidien (NYSE: COV) deal. The firm feels the deal pushes Stryker Corp. (NYSE: SYK) and Boston Scientific Corp.

    UPDATE 1-Medtronic's Covidien deal raises bar for rivals to merge
    5:04 PM ET, 06/16/2014 - Reuters
    UK-based Smith & Nephew Plc, which has already attracted takeover interest from companies seeking better tax rates overseas, remains high on the list of targets, they said. Device makers such as Boston Scientific Corp should feel more pressure to get bigger or face being left out in the cold.

    I have taken a small nibble and am awaiting developments. Any comments from other shareholders?

    Sentiment: Hold

  • Reply to


    by mekong22 Jun 5, 2014 2:45 PM fretfulporpentine Jun 7, 2014 10:30 PM Flag

    I said TRADE you fecking rabid mad dog. He cannot SELL the options at more than $0.05 any longer. If he holds till the options are accelerated at the close, the $0.10 he gets back will not cover the $0.10 + commission he paid for them (and in many cases he paid more than that).

    You are one of the most obnoxious swine to ever grace these boards and it will be a pleasure never to see your stinking posts again. BTW, are you enjoying having your smell arsch kicked by the whiney arb guy?

  • fretfulporpentine Jun 7, 2014 3:33 AM Flag

    Yeah, reading the Form SC 14D9/A Chelsea Therapeutics Filed by: Chelsea Therapeutics International, Ltd. mailed out to shareholders and filed with the SEC. Reading the high/low estimates I'd say CVR could be zero, could be 30 cents, very unlikely to be $1.50 over three years.

    Sentiment: Hold

  • Reply to


    by mekong22 Jun 5, 2014 2:45 PM fretfulporpentine Jun 7, 2014 3:07 AM Flag

    YONG 01/15/2016 7.00 C
    Last Trade 0.05 Volume 1,185 Underlying Type Equity
    Open 0.05 Open Interest 22994 Expiration Type Standard
    Change -0.05 Change % -50.0

    Anyone taking your advice on Jun 5, 2014 2:45 PM would have lost 50%. The options will never trade at $0.10 again because of commission costs. Since the bid/ask increments are $0.05 they will now trade at $0.05 until the stock is delisted.


  • Reply to


    by mekong22 Jun 5, 2014 2:45 PM fretfulporpentine Jun 5, 2014 10:46 PM Flag

    You seem determined to continue to give money-losing advice to your rapidly shrinking band of homies. Do you have any idea on how high commissions are on options? Especially as a percentage when trading a large number of penny options. Do you have any idea on how long anyone would have to wait before the stock gets delisted and they get 90% (if that) of their money back. Take an elementary course in probability and risk/reward ratios and then go back to school and learn all about the efficient market hypothesis (it actually works, unlike the advice spewed by you self-described internet experts).

    Sentiment: Hold

  • Reply to

    $7.10 is 3x - 4x undervalue

    by jfrere May 29, 2014 8:21 PM fretfulporpentine Jun 4, 2014 11:27 PM Flag

    How are those 2016 $7 calls doing meeky baby? A few months ago you were boasting about your 1000% gains on them. Did you book your profits, if any? I don't think so, there is still an Open Interest of 23000+. In fact, some loonies have been buying a few hundreds at $0.15, $0.20, $0.25. Apparently they hope desperately that history will repeat itself and the buyout will fail.

    But Mark Twain said that "History does not repeat itself, but it does rhyme." Quickest way to loose 50% of one's investment in my opinion.

  • by fretfulporpentine Jun 4, 2014 11:11 PM Flag

    Yesterday bought at $58.25, today sold at $69.25. Now that's the way the stock market should work!

  • Reply to

    $7.10 is 3x - 4x undervalue

    by jfrere May 29, 2014 8:21 PM fretfulporpentine May 31, 2014 1:19 AM Flag

    Have you or any of the other whiners paid one red cent of your money to a lawyer who will actually file a complaint and follow up on it for a period of years for free? Here's how the contingency lawyers and shysters like Tripp Levy, Willie Briscoe, etc., (who always come out of the woodwork when M&A action occurs) make their living. They consolidate the claims against the board for failing their fiduciary duty and then ask the court for payment of their inflated hourly rates. The companies settle and pay up because their boards are covered by insurance and the few hundred thousand they pay is considered a nuisance cost of doing business. The lawyers make a pretty good living at this scam.The Delaware court is now fighting back against these shysters, but that is pretty much what you can expect from any lawyers you people are putting your faith in.

    In about 3-6 months every shareholder (including those who were not a party to the suit) will receive a thick enclosure of impenetrable legalese in the mail. If you bother to read it, it will say that the lead plaintiff has settled the case, court costs have been paid by the company, and the board has denied all wrongdoing. Net money to the shareholders -- ZILCH!

  • Reply to

    $7.10 is 3x - 4x undervalue

    by jfrere May 29, 2014 8:21 PM fretfulporpentine May 31, 2014 12:49 AM Flag

    Still gabbling nonsense, I see. What happened to your lawyer friend in Arizona? What happened to your urgent letters to the board? What happened to your loud complaints to the SEC? Down the toilet where they belong. You are a rank amateur and live in a fantasy world.

    Here's the real deal. If the company was being stolen from you tiny shareholders, you had only to persuade a hedge fund to take a large position and push for an increase in the offer price closer to your fantasy price. That is what is happening right now with HSH and NDZ and other deal stocks. Morgan Stanley actually did request an increase and has obviously lined up the other big shareholders who would have otherwise have voiced their disagreement publicly. The stock dropped to the low $5's after the first vote. That was the time to buy,but you clowns obviously don't have the money to put where your mouths are. It then rose to $6 and stayed pretty constant because rumors of the Morgan Stanley offer must have leaked. After the $7 offer was announced it jumped to $6.80, and after the board accepted at $7.10 the discount has narrowed to almost nothing. The options trading indicates that almost no one expects an outcome over $8. The deal will almost certainly go through and I, for one, am delighted since I have held a large position for less than six months and will be making a large profit on it.

  • Reply to

    Dear Lord

    by optimist2929 Apr 15, 2014 4:52 PM fretfulporpentine Apr 16, 2014 2:38 AM Flag

    Is he master of his own domain? That is the question.

    Sentiment: Hold

  • fretfulporpentine Apr 13, 2014 8:36 PM Flag

    PACT closed more than a month ago. The ADR "cancellation fee" was a swingeing $0.05 assessed by the #$%$ American Bank which acted as its custodian.

    CEDU will hold its meeting on Apr. 18. It's a sure deal.

    Simcere Pharma GP closed in Jan 2014. The ADR passthru fee was about $0.04

    NED Merger is currently expected to close during the second or third quarter of 2014. Members of the Consortium have agreed to vote all of their ordinary shares of the Company in favor of such approval. This represents voting commitments from shareholders beneficially owning approximately 68% of the Company's outstanding ordinary shares (including ordinary shares represented by ADSs).

    Le Gaga (GAGA) has the largest current discount, $3.75 to the offer of $4.01 made in May 2013. SC 13D's have been filed by YIHENG CAPITAL PARTNERS LP, SEQUOIA CAPITAL CHINA I LP, Chiu Na Lai, Ma Shing Yung. Also in the business of providing vegetables grown in greenhouses. Considered undervalued, so may increase its offer.

    Sentiment: Hold

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.